Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Sleep  COVID-19 treatment studies for Sleep  C19 studies: Sleep  Sleep   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ PASC, sleep 17% Improvement Relative Risk PASC, healthy lifestyle 49% Hospitalization, healthy lif.. 78% Wang et al. Sleep for COVID-19 LONG COVID Does better sleep reduce the risk of Long COVID (PASC)? Prospective study of 1,981 patients in the USA (Apr 2020 - Nov 2021) Lower PASC with higher quality sleep (p=0.0084) Wang et al., JAMA Internal Medicine, doi:10.1001/jamainternmed.2022.6555 Favors good sleep Favors control
Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition
Wang et al., JAMA Internal Medicine, doi:10.1001/jamainternmed.2022.6555
Wang et al., Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition, JAMA Internal Medicine, doi:10.1001/jamainternmed.2022.6555
Feb 2023   Source   PDF  
  All Studies   Meta
Prospective analysis of 32,249 women, showing lower risk of PASC with a healthy lifestyle, in a dose-dependent manner. Participants with 5 or 6 healthy lifestyle factors had significantly lower COVID-19 hospitalization and PASC. BMI and sleep were independently associated with risk of PASC.
risk of PASC, 17.0% lower, RR 0.83, p = 0.008, higher quality sleep 541 of 1,334 (40.6%), lower quality sleep 330 of 647 (51.0%), NNT 9.6, adjusted per study, 7-9 hours vs. <7 or >9, multivariable, model b.
risk of PASC, 49.0% lower, RR 0.51, p = 0.002, higher quality sleep 188, lower quality sleep 66, 5 or 6 healthy lifestyle factors vs. 0.
risk of hospitalization, 78.1% lower, RR 0.22, p = 0.006, higher quality sleep 5 of 188 (2.7%), lower quality sleep 8 of 66 (12.1%), NNT 11, 5 or 6 healthy lifestyle factors vs. 0.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Wang et al., 6 Feb 2023, prospective, USA, peer-reviewed, survey, mean age 64.7, 8 authors, study period April 2020 - November 2021.
Contact: siwenwang@hsph.harvard.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperSleepAll
Abstract: Research JAMA Internal Medicine | Original Investigation Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition Siwen Wang, MD; Yanping Li, PhD; Yiyang Yue, MS; Changzheng Yuan, ScD; Jae Hee Kang, ScD; Jorge E. Chavarro, MD, ScD; Shilpa N. Bhupathiraju, PhD; Andrea L. Roberts, PhD Supplemental content IMPORTANCE Few modifiable risk factors for post–COVID-19 condition (PCC) have been identified. OBJECTIVE To investigate the association between healthy lifestyle factors prior to SARS-CoV-2 infection and risk of PCC. DESIGN, SETTING, AND PARTICIPANTS In this prospective cohort study, 32 249 women in the Nurses’ Health Study II cohort reported preinfection lifestyle habits in 2015 and 2017. Healthy lifestyle factors included healthy body mass index (BMI, 18.5-24.9; calculated as weight in kilograms divided by height in meters squared), never smoking, at least 150 minutes per week of moderate to vigorous physical activity, moderate alcohol intake (5 to 15 g/d), high diet quality (upper 40% of Alternate Healthy Eating Index–2010 score), and adequate sleep (7 to 9 h/d). MAIN OUTCOMES AND MEASURES SARS-CoV-2 infection (confirmed by test) and PCC (at least 4 weeks of symptoms) were self-reported on 7 periodic surveys administered from April 2020 to November 2021. Among participants with SARS-CoV-2 infection, the relative risk (RR) of PCC in association with the number of healthy lifestyle factors (0 to 6) was estimated using Poisson regression and adjusting for demographic factors and comorbidities. RESULTS A total of 1981 women with a positive SARS-CoV-2 test over 19 months of follow-up were documented. Among those participants, mean age was 64.7 years (SD, 4.6; range, 55-75); 97.4% (n = 1929) were White; and 42.8% (n = 848) were active health care workers. Among these, 871 (44.0%) developed PCC. Healthy lifestyle was associated with lower risk of PCC in a dose-dependent manner. Compared with women without any healthy lifestyle factors, those with 5 to 6 had 49% lower risk (RR, 0.51; 95% CI, 0.33-0.78) of PCC. In a model mutually adjusted for all lifestyle factors, BMI and sleep were independently associated with risk of PCC (BMI, 18.5-24.9 vs others, RR, 0.85; 95% CI, 0.73-1.00, P = .046; sleep, 7-9 h/d vs others, RR, 0.83; 95% CI, 0.72-0.95, P = .008). If these associations were causal, 36.0% of PCC cases would have been prevented if all participants had 5 to 6 healthy lifestyle factors (population attributable risk percentage, 36.0%; 95% CI, 14.1%-52.7%). Results were comparable when PCC was defined as symptoms of at least 2-month duration or having ongoing symptoms at the time of PCC assessment. CONCLUSIONS AND RELEVANCE In this prospective cohort study, pre-infection healthy lifestyle was associated with a substantially lower risk of PCC. Future research should investigate whether lifestyle interventions may reduce risk of developing PCC or mitigate symptoms among individuals with PCC or possibly other postinfection syndromes. JAMA Intern Med. doi:10.1001/jamainternmed.2022.6555 Published online February 6, 2023. Author Affiliations: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Wang, Li, Yue, Yuan, Chavarro, Bhupathiraju); Zhejiang University School of Public Health, Hangzhou, China (Yuan); Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts (Kang,..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop